3503-C A PHASE 2a, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY, TOLERABILITY, EFFICACY, AND PHARMACOKINETICS OF INT-787 IN SUBJECTS WITH SEVERE ALCOHOL-ASSOCIATED HEPATITIS: STUDY DESIGN, OBJECTIVES, AND NOVEL ASSESSMENTS Thomas Capozza, Steven Lauder, Sam Madison and Jennifer Callahan, Intercept Pharmaceuticals, Inc., Morristown, NJ Background: Severe alcohol-associated hepatitis (sAH) is the most acute and serious form of alcohol-associated liver disease
Check Payer-Specific Policies Each payer has its quirks
Valuable Tool in Peptide Neurobiology Research Due to its simple structure and clear physiological relevance, DSIP is an important research peptide for investigating brain signaling peptides, sleep mechanisms, and neurochemical balance
Inclusion in SUS, Brazil's free-at-point-of-use public health system, would require a further recommendation from Conitec (Brazil's technology incorporation commission) and final approval from the Ministry of Health a process that has not yet been initiated for any of the new products
Slow titration minimizes the risk of gastrointestinal side effects, such as nausea or digestive discomfort